QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine

被引：15
|
作者：
Monzani, Alice [1 ]
Genoni, Giulia [2 ]
Scopinaro, Alice [3 ]
Pistis, Gianfranco [3 ]
Kozel, Daniela [3 ]
Secco, Gioel Gabrio [3 ]
机构：
[1] Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy
[2] Azienda Osped Univ Maggiore Carita, Neonatal & Pediat Intens Care Unit, Novara, Italy
[3] Azienda Osped SS Antonio & Biagio & Cesare Arrigo, Dept Cardiol, Alessandria, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2020年 / 50卷 / 06期
关键词：
D O I：
10.1111/eci.13258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor
    Danjuma, Mohammed I.
    Sinha, Urshita
    Fatima, Haajra
    Mohamed, Mouhand F. H.
    Nathoe, Hendrik
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (11)
  • [2] Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon
    Bivigou, Elsa Ayo
    Boulingui, Charlene Manomba
    Bouraima, Aridath
    Allognon, Christian
    Konde, Christelle Akagha
    Atsame, Gabrielle
    Kinga, Armel
    Boguikouma, Jean B.
    Ndouongo, Philomene Kouna
    Akotet, Marielle K. Bouyou
    [J]. CLINICS AND PRACTICE, 2022, 12 (04) : 482 - 490
  • [3] QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
    Grewal, Sarah
    Jankelson, Lior
    van den Broek, Marcel P. H.
    Cour, Martin
    Bachmann, Gloria
    Kostis, John B.
    Misra, Kamana
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [4] Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
    Mahmoudi, Javad
    Sadigh-Eteghad, Saeed
    Salehi-Pourmehr, Hanieh
    Gharekhani, Afshin
    Ziaee, Mojtaba
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2021, 11 (01) : 6 - 7
  • [5] COVID-19 AND QTC: IS HYDROXYCHLOROQUINE WORTH THE RISK? A REVIEW OF QT PROLONGATION IN HOSPITALISED COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN
    Pollock, A.
    Kumar, R.
    Devitt, P.
    Kent, B.
    Daly, C.
    [J]. HEART, 2020, 106 : A1 - A1
  • [6] Chloroquine and hydroxychloroquine in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [7] The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
    Sinkeler, F. S.
    Berger, F. A.
    Muntinga, H. J.
    Jansen, M. M. P. M.
    [J]. NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 418 - 423
  • [8] The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
    F. S. Sinkeler
    F. A. Berger
    H. J. Muntinga
    M. M. P. M. Jansen
    [J]. Netherlands Heart Journal, 2020, 28 : 418 - 423
  • [9] Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19
    Mazzanti, Andrea
    Briani, Martina
    Kukavica, Deni
    Bulian, Francesca
    Marelli, Stefano
    Trancuccio, Alessandro
    Monteforte, Nicola
    Manciulli, Tommaso
    Morini, Massimo
    Carlucci, Annalisa
    Viggiani, Giacomo
    Cannata, Francesco
    Negri, Sara
    Bloise, Raffaella
    Memmi, Mirella
    Gambelli, Patrick
    Carbone, Andrea
    Molteni, Martina
    Bianchini, Raffaella
    Salgarello, Rita
    Sozzi, Silvia
    De Cata, Pasquale
    Fanfulla, Francesco
    Ceriana, Piero
    Locatelli, Carlo
    Napolitano, Carlo
    Chiovato, Luca
    Tomasi, Luca
    Stefanini, Giulio G.
    Condorelli, Gianluigi
    Priori, Silvia G.
    [J]. CIRCULATION, 2020, 142 (05) : 513 - 515
  • [10] QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis
    Diaz-Arocutipa, Carlos
    Branez-Condorena, Ana
    Hernandez, Adrian V.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (06) : 694 - 706
12345